Get more information on Urinalysis Market - Request Sample Report
The Urinalysis Market size was valued at USD 3.05 billion in 2023 and is expected to reach USD 5.83 billion by 2032, and grow at a CAGR of 7.49% over the forecast period 2024-2032.
Urinalysis is a urine sample analysis test that aids in the detection of a variety of conditions like diabetes, kidney disease, and urinary tract infection. Its main goal is to keep track of people's health. Urinalysis is performed as part of a general medical check-up, as part of pre-surgery preparation, as part of a pregnancy check-up, or as part of a hospital admission for various diseases. It also aids in determining the source of symptoms like back pain, abdominal pain, and uncomfortable urination.
The increasing frequency of kidney illnesses, the adoption of PPACA, and the growing geriatric population are all factors driving the global urinalysis market forward. Meanwhile, the US government's imposition of an excise tax and strong regulations procedures are limiting the market's expansion. Integrated systems and urinalysis via cellphones, as well as technical advancements, give business potential.
DRIVERS
The elderly population is growing.
Urinary parcel disease is turning out to be more normal.
Constant renal illness is turning out to be more normal over the world.
RESTRAINTS
Reimbursement situation that is not favourable
OPPORTUNITIES
Urinalysis growth possibilities in developing economies
Development of technology in urinalysis
CHALLENGES
The supervisory environment could make growth even more difficult.
The COVID-19 epidemic had a negative impact on most businesses' overall sales. Lockdowns arising from the COVID-19 epidemic forced people to put off getting their health checked, reducing the amount of tests conducted and reagent sales. Nevertheless, as governments gradually loosen travel restrictions, there is a rebound in testing numbers. People hospitalized with COVID-19 are at a high risk of AKI, which can lead to serious illness, dialysis, and even death, as per the National Kidney Foundation.
The reclaimed COVID-19 people with AKI or ARF (acute renal failure) should see a kidney doctor on a frequent basis because their risk of chronic kidney disease is more than others. Patients with COVID-19 who did not develop AKI but had blood or protein in their urine should be closely watched because they have a greater risk of getting the chronic and end-stage renal disease. With the COVID-19 pandemic, there is an increasing desire for the development of more accurate and simple testing methods, as well as the growth of testing structures, in addition to vaccinations and therapeutic medications.
As governments and healthcare providers confront extraordinary problems, COVID-19 has an impact on the regulatory environment and practises. Government regulators used a variety of techniques to expedite the approval of diagnostic products. Organizations have gone with vital choices to execute COVID-19 fast tests, keep up with income, and moderate COVID-19's effect on their working abilities.
Urinalysis Market Estimation
The worldwide urinalysis market is separated into the product, test type, application, end client. The dipstick, reagent, urine analyzer, and POC product segments are further divided. Biochemical, sediment, and microscopic tests are addressed in the study. The paper covers diagnosis, diabetes, urinary tract infections, kidney disease, and pregnancy. The report's end consumers include homes, hospitals, and research organizations.
By Product Type
Consumables
Pregnancy & Fertility Kits
Reagents
Dipsticks
Disposables
Instruments
Automated Urine Analyzers
Point-of-Care Urine Analyzers
Semi-automated Urine Analyzers
By Test
Pregnancy & Fertility Tests
Sediment Urinalysis
Biochemical Urinalysis
POC Tests
Laboratory Tests
By Application
Disease Screening
Urinary Tract Infections
Liver Diseases
Kidney Diseases
Diabetes
Other
Pregnancy and Fertility
By End User
Diagnostic Laboratories
Home Care Settings
Research Laboratories
Hospitals and Clinics
North America, Europe, Asia Pacific, and the Rest of the World make up the urinalysis market. North America held the highest proportion of the worldwide urinalysis market in 2023. The growing elderly population, implementation of favourable government programmes, increased healthcare expenditure, improved healthcare infrastructure, and the availability of technologically advanced instruments all contribute to the growth of the North American urinalysis market.
Need any customization research on Urinalysis Market - Enquiry Now
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Some of the major key players are as follows are Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, Elektronika KFT, Arkray Inc., Beckman Coulter Inc., Mindray Medical International Limited, URIT Medical Electronic Group Co. Ltd., Acon Laboratories Inc., Bio-Rad Laboratories Inc, and other players.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 3.05 Billion |
| Market Size by 2032 | USD 5.83 Billion |
| CAGR | CAGR of 7.49% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product Type (Consumables (Pregnancy & Fertility Kits, Reagents, Dipsticks, Disposables) • By Instruments (Automated Urine Analyzers, Point-of-Care Urine Analyzers, Semi-automated Urine Analyzers) • By Test (Pregnancy & Fertility Tests, Sediment Urinalysis, Biochemical Urinalysis) • By Application (Disease Screening, Pregnancy and Fertility) • By End User (Diagnostic Laboratories, Home Care Settings, Research Laboratories, Hospitals and Clinics) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, Elektronika KFT, Arkray Inc., Beckman Coulter Inc., Mindray Medical International Limited, URIT Medical Electronic Group Co. Ltd., Acon Laboratories Inc., Bio-Rad Laboratories Inc, and other players. |
| Drivers | • The elderly population is growing. • Urinary parcel disease is turning out to be more normal. • Constant renal illness is turning out to be more normal over the world. |
| Restraints | • Reimbursement situation that is not favourable |
The Urinalysis Market is growing at a CAGR of 7.49% over the forecast period 2024-2032.
The Urinalysis Market Size was valued at USD 3.05 Bn in 2023.
The urinalysis Market is divided into four segments and they are By Product Type, By Test Type, By Application Type, and, By End User Type
North America held the highest proportion of the urinalysis market.
Manufacturer and service provider, research institutes, universities, and private libraries, suppliers, and distributors.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8 Urinalysis Market Segmentation, by Product Type
8.1 Consumables
8.1.1 Pregnancy & Fertility Kits
8.1.2 Reagents
8.1.3 Dipsticks
8.1.4 Disposables
8.2 Instruments
8.2.1 Automated Urine Analyzers
8.2.3 Point-of-Care Urine Analyzers
8.2.4 Semi-automated Urine Analyzers
9. Urinalysis Market Segmentation, By Test Type
9.1 Pregnancy & Fertility Tests
9.2 Sediment Urinalysis
9.3 Biochemical Urinalysis
9.3.1 POC Tests
9.3.2 Laboratory Tests
10. Urinalysis Market Segmentation, By Application Type
10.1 Disease Screening
10.1.1 Urinary Tract Infections
10.1.2 Liver Diseases
10.1.3 Kidney diseases
10.1.4 Diabetes
10.1.5 Other
10.2 Pregnancy and Fertility
11. Urinalysis Market Segmentation, By End User Type
11.1 Diagnostic Laboratories
11.2 Home Care Settings
11.3 Research Laboratories
11.4 Hospitals and Clinics
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 USA
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 France
12.3.4 Italy
12.3.5 Spain
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4 Asia-Pacific
12.4.1 Japan
12.4.2 South Korea
12.4.3 China
12.4.4 India
12.4.5 Australia
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.1 Israel
12.5.2 UAE
12.5.3 South Africa
12.5.4 Rest
12.6 Latin America
12.6.1 Brazil
12.6.2 Argentina
12.6.3 Rest of Latin America
13. Company Profiles
13.1 Roche Diagnostics
13.1.1 Financial
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.2 Siemens Healthcare
13.3 Sysmex Corporation
13.4 Elektronika KFT
13.5 Arkray Inc.
13.6 Beckman Coulter Inc.
13.7 Roche Diagnostics
13.8 Mindray Medical International Limited
13.9 URIT Medical Electronic Group Co. Ltd.
13.10 Acon Laboratories Inc.
13.11 Bio-Rad Laboratories Inc.
14. Competitive Landscape
14.1 Competitive Benchmark
14.2 Market Share Analysis
14.3 Recent Developments
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Healthcare Data Storage Market Size was valued at USD 4.7 Bn in 2023 and will reach to USD 15.54 Bn by 2032 and grow at a CAGR of 14.23% by 2024-2032.
The Dentures Market was valued USD 1.62 Billion in 2023 and estimated to reach USD 3.00 Billion by 2032 at compound annual growth rate 7.10% during the forecast period 2024-2032.
The Mass Spectrometry Market size was valued at USD 5.76 billion in 2023 and is projected to reach USD 11.25 billion by 2032 at a CAGR of 7.74% from 2024 to 2032
The ultrasound equipment market size was valued at USD 9.47 billion in 2023, and is expected to reach USD 15.22 billion by 2032, and grow at a CAGR of 5.43% over the forecast period 2024-2032.
The Contrast Media/Contrast Agent Market Size was valued at USD 6.50 Billion in 2023, and is expected to reach USD 12.28 Billion by 2032, and grow at a CAGR of 7.66%.
The Medical Robots Market Size was USD 14.9 billion in 2023 and is expected to reach USD 57.0 billion by 2032 and grow at a CAGR of 16.06% by 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
